NEWS
NEWS
NEWS
HOW ONE CEO IS CHANGING LIFE SCIENCES INNOVATION
June 23, 2021
Jeff Aronin discusses why Paragon Biosciences’ unique company incubator approach results in an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry.
Access the entire interview here:
https://chiefexecutive.net/how-one-ceo-is-changing-life-sciences-innovation
RECENT NEWS
EVOZYNE: ENGINEERING BIOLOGY TO SOLVE SOCIETAL CHALLENGES
TALES FROM THE TRENCHES: JEFF ARONIN INTERVIEWS NANOTECH EXPERT CHAD MIRKIN
HOW JEFF ARONIN BEGAN BUILDING LIFE SCIENCES COMPANIES AND NEVER STOPPED
JEFF ARONIN ON BOOMING LIFE SCIENCES SUCCESS IN CHICAGO
JEFF ARONIN RECOGNIZES EVOZYNE FOR UNLOCKING THE POTENTIAL OF NOVEL PROTEINS
HOW ONE CEO IS CHANGING LIFE SCIENCES INNOVATION
June 23, 2021
Jeff Aronin discusses why Paragon Biosciences’ unique company incubator approach results in an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry.
Access the entire interview here:
https://chiefexecutive.net/how-one-ceo-is-changing-life-sciences-innovation
RECENT NEWS
EVOZYNE: ENGINEERING BIOLOGY TO SOLVE SOCIETAL CHALLENGES
TALES FROM THE TRENCHES: JEFF ARONIN INTERVIEWS NANOTECH EXPERT CHAD MIRKIN
HOW JEFF ARONIN BEGAN BUILDING LIFE SCIENCES COMPANIES AND NEVER STOPPED
JEFF ARONIN ON BOOMING LIFE SCIENCES SUCCESS IN CHICAGO
JEFF ARONIN RECOGNIZES EVOZYNE FOR UNLOCKING THE POTENTIAL OF NOVEL PROTEINS
HOW ONE CEO IS CHANGING LIFE SCIENCES INNOVATION
June 23, 2021
Jeff Aronin discusses why Paragon Biosciences’ unique company incubator approach results in an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry.
Access the entire interview here:
https://chiefexecutive.net/how-one-ceo-is-changing-life-sciences-innovation
RECENT NEWS
EVOZYNE: ENGINEERING BIOLOGY TO SOLVE SOCIETAL CHALLENGES
TALES FROM THE TRENCHES: JEFF ARONIN INTERVIEWS NANOTECH EXPERT CHAD MIRKIN
HOW JEFF ARONIN BEGAN BUILDING LIFE SCIENCES COMPANIES AND NEVER STOPPED
JEFF ARONIN ON BOOMING LIFE SCIENCES SUCCESS IN CHICAGO
JEFF ARONIN RECOGNIZES EVOZYNE FOR UNLOCKING THE POTENTIAL OF NOVEL PROTEINS
